Prime Medicine, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 5.21M2.98M
Gross Profit 5.21M2.98M
Operating items
Amortization - Intangibles 5.68M3.51M
Research & Development 2.98M70.55M86.72M147.91M155.29M
Selling, General & Administrative 3.16M13.92M29.82M43.39M50.16M
Other Operating Expenses 13.50M
Operating Expenses 6.14M84.47M116.54M204.79M205.45M
Operating Income -0.93M-84.47M-116.54M-204.79M-202.47M
EBIT -0.93M-84.47M-116.54M-204.79M-202.47M
Non-operating items
Interest & Investment Income 2.81M3.52M
Other Non Operating Income 0.13M0.01M1.90M0.27M0.04M
Non Operating Income -0.61M-81.38M-6.22M6.38M6.58M
Net income details
EBT -1.54M-165.85M-122.77M-198.41M-195.88M
Tax Provisions 1.90M-0.50M-0.95M-0.28M
Profit After Tax -3.41M-165.37M-121.82M-198.13M-195.88M
Income from Continuing Operations -3.44M-165.35M-121.82M-198.13M-195.88M
Consolidated Net Income -3.44M-165.35M-121.82M-198.13M-195.88M
Income towards Parent Company -3.44M-165.35M-121.82M-198.13M-195.88M
Preferred Dividend Payments 1.65M17.28M20.19M
Net Income towards Common Stockholders -5.05M-184.12M-142.01M-198.13M-195.88M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 97.21M97.32M131.16M
Shares Outstanding (Diluted Average) 2.64M12.97M33.89M90.97M118.60M
EBITDA -3.41M-165.39M-122.18M-197.76M-195.87M
Tax Rate 0.00M0.00M0.00M